Literature DB >> 30604151

How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network.

Albino Eccher1, Letizia Lombardini2,3, Ilaria Girolami4, Francesca Puoti2, Gianluigi Zaza5, Giovanni Gambaro5, Amedeo Carraro6, Giovanni Valotto4, Luca Cima7, Luca Novelli8, Desley Neil9, Umberto Montin6,10, Aldo Scarpa4, Matteo Brunelli4, Alessandro Nanni Costa2,3, Antonia D'Errico11.   

Abstract

Guidelines for donor selection have changed to expand the donor pool, considering potential donors affected by a neoplasm. Aim of this retrospective study is to look at the use of organs from donors with a current or history of neoplasm within the Italian Transplant Network. Data, collected and validated by Italian National Health Institute for the time interval 2006-2015, have been reviewed retrospectively by mean of multivariable pivot tables. Donors with neoplasia represented about 5% of all donors, resulting in about 4% of all transplants. Donors presented a benign neoplasm in 29.08% of cases, a malignancy with variable risk of transmission in 69.75% while in 1.34% the nature of neoplasm could not be assessed. Considering all procedures, rate of transmission of a malignancy was 0.03% (10 cases) of all 29858 transplants of the time interval. Notably, cases of transmission were not from donors of this pool, but from donors that, according to our protocols, had no elements of suspect at time of donation. As recipient safety is always the priority and as guidelines have set exclusion criteria for donors with some specific types of malignancy, these results show that use of this type of donors is safe and improve organ pool. Furthermore represent basis for improvement and standardization of donor assessment protocols suggesting that efforts in data collection systems, to produce complete and homogeneous data, are mandatory.

Entities:  

Keywords:  Donor evaluation; Donor with malignancy; Neoplastic transmission; Risk assessment; Transplantation

Mesh:

Year:  2019        PMID: 30604151     DOI: 10.1007/s40620-018-00573-z

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  29 in total

Review 1.  Transmission of donor melanoma by organ transplantation.

Authors:  Dirk C Strauss; J Meirion Thomas
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

2.  Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium.

Authors:  Sandy Feng; Joseph F Buell; Ravi S Chari; J Michael DiMaio; Douglas W Hanto
Journal:  Am J Transplant       Date:  2003-12       Impact factor: 8.086

3.  First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer.

Authors:  H M Kauffman; M A McBride; F L Delmonico
Journal:  Transplantation       Date:  2000-12-27       Impact factor: 4.939

4.  Melanoma in solid organ transplant recipients.

Authors:  F O Zwald; L J Christenson; E M Billingsley; N C Zeitouni; D Ratner; J Bordeaux; M J Patel; M D Brown; C M Proby; S Euvrard; C C Otley; T Stasko
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

5.  Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.

Authors:  Sven Arvid Birkeland; Hans H Storm
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

6.  A multiorgan donor cancer screening protocol: the Italian Emilia-Romagna region experience.

Authors:  Michelangelo Fiorentino; Antonia D'Errico; Barbara Corti; Silvia Casanova; Lorenza Ridolfi; Nicola Venturoli; Elena Sestigiani; Walter F Grigioni
Journal:  Transplantation       Date:  2003-12-27       Impact factor: 4.939

7.  Transplant tumor registry: donor related malignancies.

Authors:  H Myron Kauffman; Maureen A McBride; Wida S Cherikh; Pamela C Spain; William H Marks; Allan M Roza
Journal:  Transplantation       Date:  2002-08-15       Impact factor: 4.939

8.  Donors with central nervous system malignancies: are they truly safe?

Authors:  Joseph F Buell; Jennifer Trofe; Gopalan Sethuraman; Michael J Hanaway; Thomas M Beebe; Thomas G Gross; Rita Alloway; M Roy First; E Steve Woodle
Journal:  Transplantation       Date:  2003-07-27       Impact factor: 4.939

9.  Transmission of anaplastic large cell lymphoma via organ donation after cardiac death.

Authors:  J W Harbell; T B Dunn; M Fauda; D G John; A S Goldenberg; L W Teperman
Journal:  Am J Transplant       Date:  2007-11-12       Impact factor: 8.086

10.  Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update.

Authors:  H Myron Kauffman; Wida S Cherikh; Maureen A McBride; Yulin Cheng; Douglas W Hanto
Journal:  Transplantation       Date:  2007-07-27       Impact factor: 4.939

View more
  6 in total

1.  Shared decision-making and disclosure of adverse events: critical aspects for the quality and safety of kidney transplant practice.

Authors:  Alessandra Agnese Grossi; Tullia Maria De Feo; Andrea Ambrosini; Mario Picozzi
Journal:  J Nephrol       Date:  2021-11-16       Impact factor: 3.902

2.  Diffuse Micro-Nodules on Peritoneal Surfaces at Donor Organ Procurement: Highlights on the Diagnostic Challenge and Transplant Management.

Authors:  Albino Eccher; Amedeo Carraro; Ilaria Girolami; Manuela Villanova; Alex Borin; Paola Violi; Barbara Paro; Claudia Mescoli; Deborah Malvi; Luca Novelli; Antonietta D'Errico; Giuseppe Rossini; Marco Ungari
Journal:  Am J Case Rep       Date:  2021-02-13

3.  The 3-T Model of Informed Consent for Nonstandard Risk Donors: A Proposal for Transplant Clinical Practice.

Authors:  Alessandra Agnese Grossi; Federico Nicoli; Tullia Maria De Feo; Massimo Cardillo; Gabriella Biffa; Renzo Pegoraro; Carlo Petrini; Rosanna Torelli; Francesca Puoti; Giuseppe Rossini; Giuseppe Piccolo; Sergio Vesconi; Enrico Minetti; Barbara Pozzo; Giuseppe Vanacore; David Paredes; Paolo Antonio Grossi; Mario Picozzi
Journal:  Transplant Direct       Date:  2021-10-22

4.  Impact of Thyroid Incidentaloma on Liver Transplant: A Study of 1010 Recipients at a Single Center.

Authors:  Yi-Chia Chan; Chao-Long Chen; Chih-Che Lin; Chee-Chien Yong; Yi-Ju Wu; Shun-Yu Chi; Fong-Fu Chou
Journal:  Ann Transplant       Date:  2022-02-08       Impact factor: 1.530

5.  Validation of portable tablets for transplant pathology diagnosis according to the College of American Pathologists Guidelines.

Authors:  Stefano Marletta; Liron Pantanowitz; Deborah Malvi; Luca Novelli; Claudia Mescoli; Massimo Cardillo; Antonietta D'Errico; Ilaria Girolami; Albino Eccher
Journal:  Acad Pathol       Date:  2022-07-31

6.  Donor-transmitted cancer in kidney transplant recipients: a systematic review.

Authors:  Albino Eccher; Ilaria Girolami; Jennifer Danielle Motter; Stefano Marletta; Giovanni Gambaro; Rostand Emmanuel Nguefuet Momo; Francesco Nacchia; Paola Donato; Luigino Boschiero; Ugo Boggi; Letizia Lombardini; Massimo Cardillo; Antonietta D'Errico; Desley Neil; Dorry Lidor Segev; Gianluigi Zaza
Journal:  J Nephrol       Date:  2020-06-13       Impact factor: 3.902

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.